NCT02402920View on ClinicalTrials.gov

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

July 22, 2015

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Extensive Stage Small Cell Lung CarcinomaLimited Stage Small Cell Lung CarcinomaNeuroendocrine Neoplasm
Interventions
DRUG

Carboplatin

Given IV

DRUG

Cisplatin

Given IV

DRUG

Etoposide

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Pembrolizumab

Given IV

PROCEDURE

Radiation Therapy

Undergo radiation therapy

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER